POST FDA APPROVAL EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUSION IN THE UNITED STATES

The Watchman™ (Boston Scientific Corporation, MA) device for left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation was FDA approved in March of 2015. We now provide the first report of the post-approval experience with the device in the United States. Each